{"TopicDetails": {"type": 0, "ccm2Id": 31064971, "cftId": 0, "identifier": "IMI2-2014-02-05", "title": "Rapid diagnostic tests", "publicationDateLong": 1415232000000, "callIdentifier": "H2020-JTI-IMI2-2014-02-single-stage", "callTitle": "IMI2 2nd Call for proposals: IMI2 Ebola and other filoviral haemorrhagic fevers programme", "callccm2Id": 31067020, "allowPartnerSearch": true, "frameworkProgramme": {"id": 31045243, "abbreviation": "H2020", "description": "Horizon 2020 Framework Programme"}, "programmeDivision": [{"id": 31047894, "abbreviation": "EU.3.1.", "description": "Health, demographic change and wellbeing"}, {"id": 31047893, "abbreviation": "EU.3.", "description": "Societal Challenges"}, {"id": 31062059, "abbreviation": "EU.3.1.7.", "description": "Innovative Medicines Initiative 2 (IMI2)"}, {"id": 31045244, "abbreviation": "EC", "description": "EC Treaty"}], "topicMGAs": [], "tags": ["Manufacturing", "Diagnostics", "Deployment of vaccines", "Filovirus", "Phase I, II, III clinical trials", "Cold chain", "Ebola", "Adherence to vaccination regimen", "Biosafety level laboratory", "Vaccine development", "Thermo-stability", "Haemorrhagic fever"], "keywords": ["Research integrity and research misconduct", "Mobile devices", "Prevention and treatment of infection by pathogens", "Viruses", "Regulatory framework for innovation", "Diagnostic and implantable devices, environmental", "Public Private Partnerships (PPP)", "Virology", "Privacy", "Emerging Epidemics", "Public health and epidemiology", "Drug development, clinical phases"], "flags": ["IntlCoop"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "IMI2-RIA Research and Innovation action", "typeOfMGA": []}], "plannedOpeningDate": "06 November 2014", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["01 December 2014"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3272913": [{"action": "IMI2-2014-02-02 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "06 November 2014", "deadlineModel": "single-stage", "deadlineDates": ["01 December 2014"], "budgetYearMap": {"0": 280000000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2014-02-01 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "06 November 2014", "deadlineModel": "single-stage", "deadlineDates": ["01 December 2014"], "budgetYearMap": {"0": 280000000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2014-02-03 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "06 November 2014", "deadlineModel": "single-stage", "deadlineDates": ["01 December 2014"], "budgetYearMap": {"0": 280000000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2014-02-04 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "06 November 2014", "deadlineModel": "single-stage", "deadlineDates": ["01 December 2014"], "budgetYearMap": {"0": 280000000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2014-02-05 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "06 November 2014", "deadlineModel": "single-stage", "deadlineDates": ["01 December 2014"], "budgetYearMap": {"0": 280000000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["0"]}, "description": "<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>Specific challenge </p><p>Rapid detection of Ebola infections in the field or at decentralised healthcare centers is an urgent need in the current crisis of the outbreak of EVD and will remain important even after the current crisis may have subsided. Additional technologies addressing various healthcare facilities settings will also be important to maintain surveillance in the long term. Current PCR-based tests have a number of limitations related to time and procedures requiring infrastructures and specific training. Tools and technologies are needed to provide quality diagnostics at low cost. Several such tests are already under development but their performance and practicability are unknown.</p><p> Scope </p><p>The project(s) will work on developing rapid diagnostics to detect EVD at acceptable costs and with very high sensitivity and specificity. At a minimum a rapid diagnostic test should be able to be deployed at decentralised health care facilities under conditions with minimum laboratory infrastructures available. Projects can work on validating existing tests or on expanding the use of tools currently being developed, through clinical validation to registration and launch. Projects must in any case include a phase of clinical validation in the field under real-world conditions, address manufacturing and access path to ensure sustainable distribution including taking into account ethical considerations and the health systems context. Any suitable technology can be used but the focus should be on practical solutions that meet the following criteria:</p><p>-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Very high sensitivity and specificity</p><p>-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Ability to be deployed in resource-limited settings</p><p>-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Minimal training required to operate</p><p>-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Capability of multiplexing in order to include different ebola strains</p><p>-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Time to result 15-30 minutes (desirable) \u2013 3 hours (acceptable)</p><p>-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Sample type for intake: blood (capillary fingerstick desirable), other less invasive sample types (urine, etc.)</p><p>Additional capabilities to provide epidemiological monitoring (eg. Internet connectivity) would be valuable.</p><p>It is considered that an IMI2 JU financial contribution of approximately 7.5 million and an EFPIA in-kind contribution of approximately EUR 7.5 million would allow this specific challenge to be addressed appropriately. Nevertheless, this does not preclude submission and selection of proposals requesting other amounts.</p><p> Expected impact </p><p>Increased availability of rapid diagnostic tests for EVD, providing in a first step immediate impact on public health in regions where the disease is endemic.</p><p>Possible impact on business opportunities for European SMEs active in this area.</p>\n<SPAN class=\"topicdescriptionkind\">Cross-cutting Priorities</SPAN>:<p><a href=\"//ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-search;statusCodes=31094501,31094502,31094503;programCcm2Id=31045243;crossCuttingPriorityCode=IntlCoop;sortQuery=sortStatus;orderBy=asc\">International cooperation</a><br></p>\n", "conditions": "<p>Please read the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_fiches/jtis/h2020-call-fiche14-2-imi2-ju_en.pdf\">IMI2 2nd Call Topic Text</a> for full details of this topic.</p>\r\n<p>Please note that submitting proposals for this call can only be done through the<a href=\"http://sofia.imi.europa.eu/\">IMI SOFIA software tool</a>.</p>\r\n<p>Please read carefully all provisions below before the preparation of your application.</p>\r\n<ol>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">List of countries and applicable rules for funding: </span></strong>described in <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/wp/2014_2015/annexes/h2020-wp1415-annex-a-countries-rules_en.pdf\">part A of the General Annexes</a> of the General Work Programme.<br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Eligibility and admissibility conditions:</span></strong> described in the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-pse-imi-ju_en.pdf\">IMI2 Manual for evaluation, submission and grant award</a>. See also the <a href=\"http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:JOL_2014_174_R_0003\">Commission Delegated Regulation (EU) N&deg; 622/2014 of 14 February 2014</a><br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Evaluation </span></strong><br />\r\n    For a guide to the submission and evaluation process including evaluation criteria and procedure, scoring and threshold: please see the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-pse-imi-ju_en.pdf\"><strong>IMI2</strong> Manual for submission, evaluation and grant award</a><br />\r\n    See also the IMI2 RIA Proposal Template and IMI2 RIA Evaluation Form in section 6, below.&nbsp;<br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Proposal page limits and layout: </span></strong>Please refer to IMI2 RIA Proposal Template in section 6, below.<br />\r\n    &nbsp;</li>\r\n    <li><span style=\"color: rgb(0,51,102)\"><strong>Indicative timetable for evaluation and grant agreement:</strong></span><br />\r\n    Information on the outcome of <strong>one-stage </strong>evaluation: maximum&nbsp;2 months from the final date for submission.<br />\r\n    Signature of grant agreements: maximum&nbsp;1 month from the date of informing successful applicants.<br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic: </span></strong><br />\r\n    <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2_Call1/Summary_of_provisions_for_particip_2014.06.26.pdf\">Summary of the most relevant provisions for participating in IMI2 actions</a><br />\r\n    <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2_CallDocs/IMI2_proposal_template.pdf\">IMI2 RIA&nbsp;Proposal Template</a> <br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_ptef/ef/h2020-call-ef-imi2-ria_en.pdf\">IMI2 RIA Evaluation Form</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/mga/jtis/h2020-mga-imi_en.pdf\">IMI2 Model Grant Agreement</a></li>\r\n</ol>\r\n<p>&nbsp;</p>", "supportInfo": "<div>\r\n<p>Contact the <strong><a href=\"http://www.imi.europa.eu/\">IMI Programme Office</a></strong>. E-mail: <a href=\"mailto:Infodesk@imi.europa.eu\"><strong>Infodesk@imi.europa.eu</strong></a> Tel.: +32 2 221 8181</p>\r\n<p>IMI JU <a href=\"mailto:sofia@imi.europa.eu\"><strong>IT Helpdesk</strong></a>&nbsp;- contact the SOFIA IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.</p>\r\n<p><a href=\"http://www.imi.europa.eu/content/states-representatives-groups\"><strong>IMI2 States Representative Group (SRG)</strong></a> - contact your SRG member for assistance</p>\r\n<p><a href=\"http://www.imi.europa.eu/content/partner-search\"><strong>IMI Partner Search Tool</strong></a> helps you find a partner organisation for your proposal</p>\r\n<p><a href=\"http://ec.europa.eu/research/participants/portal/desktop/en/support/national_contact_points.html\"><strong>National Contact Points (NCP)</strong></a> - contact your NCP for further assistance</p>\r\n<p><a href=\"http://een.ec.europa.eu/\"><strong>Enterprise Europe Network </strong></a>&ndash; national contact points' advice to businesses with focus on SMEs. The support includes guidance on the EU research funding.</p>\r\n<p><a href=\"http://ec.europa.eu/research/index.cfm?lg=en&amp;pg=enquiries\"><strong>Research Enquiry Service</strong></a> &ndash; ask questions about any aspect of European research and EU R&amp;I programmes</p>\r\n<p><strong>Ethics</strong> &ndash; for compliance with ethical issues, see the <a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/ethics_en.htm\"><strong>Participant Portal</strong></a>&nbsp;and&nbsp;<a href=\"http://ec.europa.eu/research/science-society/index.cfm?fuseaction=public.topic&amp;id=1289&amp;lang=1\"><strong>Science and Society Portal</strong></a></p>\r\n<p><a href=\"http://ec.europa.eu/euraxess/pdf/brochure_rights/am509774CEE_EN_E4.pdf\"><strong>The European Charter for Researchers and the Code of Conduct for their recruitment</strong></a></p>\r\n<p><a href=\"http://www.cen.eu/cen/Services/Innovation/Pages/default.aspx\"><strong>CEN</strong></a> and <a href=\"http://www.cenelec.eu/aboutcenelec/whatwestandfor/fosterinnovation/randd.html\"><strong>CENELEC</strong></a>, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at <a href=\"mailto:research@cencenelec.eu\"><strong>research@cencenelec.eu</strong></a></p>\r\n</div>\r\n<p>&nbsp;</p>", "sepTemplate": "<p>Proposals must be submitted via the <strong>IMI electronic submission tool SOFIA </strong>(Submission OF Information Application) <a href=\"http://sofia.imi.europa.eu\">http://sofia.imi.europa.eu</a>. No other means of submission will be accepted.</p>\r\n<p><span style=\"color: #ff0000\"><strong>The SOFIA software tool is now open.</strong></span></p>\r\n<p>To access SOFIA, Applicant Consortium Coordinators will need to complete a Request for Access <a href=\"https://sofia.imi.europa.eu/Pages/RequestAccess.aspx\">https://sofia.imi.europa.eu/Pages/RequestAccess.aspx</a> to the tool.</p>\r\n<p>&nbsp;The proposal may be updated online prior to the submission deadline. Please note that the submit button must be pressed to submit the proposal for evaluation.</p>", "links": [{"callIdentifier": "H2020-JTI-IMI2-2014-02-single-stage", "status": "Closed", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "IMI2-RIA", "criterionDescription": "Research and Innovation action", "url": "https://sofia.imi.europa.eu", "startDate": "Nov 12, 2014 2:10:00 PM"}], "additionalDossiers": [], "infoPackDossiers": [{"callId": 6076, "id": 7103, "title": "IMI2 2nd Call Text", "sectionId": 6076, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 215022, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2014-02-05/1630119-imi2_call-2_text_en.pdf", "id": 1630119, "fileName": "IMI2_Call-2_TEXT_en.pdf", "common": false, "crc32": 2637167466}]}, {"callId": 6076, "id": 7107, "title": "IMI2 RIA Proposal Template", "sectionId": 6076, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 426859, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2014-02-05/1632615-imi2_proposal_template_en.pdf", "id": 1632615, "fileName": "IMI2_proposal_template_en.pdf", "common": false, "crc32": 2192056097}]}, {"callId": 6076, "id": 7111, "title": "IMI2 RIA Evaluation Form", "sectionId": 6076, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 526638, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2014-02-05/1630120-h2020-call-ef-imi2-ria_en.pdf", "id": 1630120, "fileName": "h2020-call-ef-imi2-ria_en.pdf", "common": false, "crc32": 703482679}]}, {"callId": 6076, "id": 7115, "title": "IMI2 Manual for evaluation, submission and grant award", "sectionId": 6076, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 522336, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2014-02-05/1630122-h2020-guide-pse-imi-ju_en.pdf", "id": 1630122, "fileName": "h2020-guide-pse-imi-ju_en.pdf", "common": false, "crc32": 3844090519}]}, {"callId": 6076, "id": 7119, "title": "Summary of the most relevant provisions for participating in IMI2 actions", "sectionId": 6076, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 617313, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2014-02-05/1630123-imi2_summary_of_provisions_en.pdf", "id": 1630123, "fileName": "IMI2_Summary_of_provisions_en.pdf", "common": false, "crc32": 2442866750}]}], "callDetailsJSONItem": {"additionalInfo": "<p>For full information on this call, please refer to the <a href=\"http://www.imi.europa.eu/content/imi-2-call-2-0\">Call 2 section of the IMI website</a>.</p>\r\n<p>Please note that submitting short proposals for this call can only by done through the <a href=\"https://sofia.imi.europa.eu/Pages/Default.aspx\"><strong>IMI SOFIA submission tool</strong></a>. This tool will open for submissions on 25 November 2014.&nbsp; Prior to this date, you may prepare your Full Proposal according to the <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2_CallDocs/IMI2_proposal_template.doc\">IMI2 RIA Proposal Template</a>.<br />\r\n&nbsp;</p>", "latestInfos": [{"approvalDate": "Feb 2, 2015 1:56:50 PM", "lastChangeDate": "Feb 2, 2015 1:56:25 PM", "content": "<p><strong>Call Submission Information:</strong></p>\r\n<p>Proposals submitted: 19<br />\r\nInadmissible &amp; ineligible proposals: 5<br />\r\nProposals&nbsp;recommended for funding: 8<br />\r\nPropoals not recommended for funding: 6</p>"}, {"approvalDate": "Nov 25, 2014 4:15:23 PM", "lastChangeDate": "Nov 25, 2014 3:09:53 PM", "content": "<p><span style=\"color: #ff0000\"><strong>The SOFIA&nbsp;submission tool is now open </strong></span>at <a href=\"http://sofia.imi.europa.eu\">http://sofia.imi.europa.eu</a></p>\r\n<p>To access SOFIA, Applicant Consortium Coordinators will need to complete a Request for Access: <a href=\"https://sofia.imi.europa.eu/Pages/RequestAccess.aspx\">https://sofia.imi.europa.eu/Pages/RequestAccess.aspx</a></p>\r\n<p>As of 21 November, the <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2_CallDocs/IMI2_proposal_template.doc\">proposal template </a>has now been updated to include the Ethics Issues Table. All consortia must complete the Ethics Issues Table; if you have already started to fill in the form using the old template, simply copy and paste the table across.</p>\r\n<p>Questions about the Ebola+ programme? Read our <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2Call2/Ebola_Call_FAQs_20141121.pdf\">Frequently Asked Questions</a> (version of 21 November 2014)</p>"}, {"approvalDate": "Nov 21, 2014 5:02:42 PM", "lastChangeDate": "Nov 21, 2014 4:59:35 PM", "content": "<p>The SOFIA&nbsp;submission tool is expected to open on 25 November 2014</p>\r\n<p>As of 21 November, the <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2_CallDocs/IMI2_proposal_template.doc\">proposal template </a>has now been updated to include the Ethics Issues Table. All consortia must complete the Ethics Issues Table; if you have already started to fill in the form using the old template, simply copy and paste the table across. Guidance on how to fill in the table can be found in this guide <br />\r\n&nbsp;</p>\r\n<p>Questions about the Ebola+ programme? Read our <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2Call2/Ebola_Call_FAQs_20141121.pdf\">Frequently Asked Questions</a> (version of 21 November 2014)</p>"}, {"approvalDate": "Nov 12, 2014 2:17:19 PM", "lastChangeDate": "Nov 12, 2014 2:17:19 PM", "content": "The submission session is now available for: IMI2-2014-02-01(IMI2-RIA), IMI2-2014-02-02(IMI2-RIA), IMI2-2014-02-03(IMI2-RIA), IMI2-2014-02-04(IMI2-RIA), IMI2-2014-02-05(IMI2-RIA)"}, {"approvalDate": "Nov 11, 2014 10:13:20 AM", "lastChangeDate": "Nov 11, 2014 10:13:06 AM", "content": "<p>&nbsp;</p>\r\n<p>Questions about the Ebola+ programme? Read our <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2Call2/Ebola_Call_FAQs_20141110.pdf\"><strong>Frequently Asked Questions</strong></a></p>\r\n<p>Want to learn more about the Ebola Call? Sign up for one of the <a href=\"http://www.imi.europa.eu/events/2014/11/02/ebola-webinars-2014\"><strong>webinars</strong></a> on 12 November or 17 November at 14:00 CET</p>\r\n<p>IMI&rsquo;s <a href=\"http://www.imi.europa.eu/content/partner-search\"><strong>Partner Search Tool</strong></a> allows people interested in applying for IMI Call to search for potential project partners. You can find and contact partners from industry and other sectors in the Partner Search Tool.</p>"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}